American International Group, Inc. Surface Oncology, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.42 - $3.15 $24,918 - $55,276	-17,548 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.65 - $5.08 $3,275 - $6,278	-1,236 Reduced 6.58%	17,548 $52,000
Q4 2021 Feb 11, 2022	SELL	$4.73 - $7.9 $1,305 - $2,180	-276 Reduced 1.45%	18,784 $90,000
Q3 2021 Nov 12, 2021	BUY	$5.16 - $7.98 $2,146 - $3,319	416 Added 2.23%	19,060 $144,000
Q2 2021 Aug 13, 2021	BUY	$6.45 - $9.09 $120,253 - $169,473	18,644 New	18,644 $139,000
Q2 2019 Aug 13, 2019	SELL	$2.75 - $4.89 $19,822 - $35,247	-7,208 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$4.11 - $5.88 $957 - $1,370	-233 Reduced 3.13%	7,208 $34,000
Q4 2018 Feb 13, 2019	BUY	$3.65 - $10.69 $9,563 - $28,007	2,620 Added 54.35%	7,441 $32,000
Q3 2018 Nov 09, 2018	BUY	$8.92 - $17.83 $767 - $1,533	86 Added 1.82%	4,821 $53,000
Q2 2018 Aug 08, 2018	BUY	$12.83 - $17.41 $60,750 - $82,436	4,735 New	4,735 $77,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.